The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic ...

Peripheral edema, particularly of the lower limbs, is one of the most common adverse effects of dihydropyridine calcium channel blockers and may result in the need for dose reduction or drug ...

There are many possible causes of bone marrow edema, ranging from arthritis and bone injury to more serious or debilitating ...

Moss collapsed during a run at Wright Park on Sunday, according to a GoFundMe created for her. She was life-flighted to ...

The Global Edema Clinical Trials Market is valued at approximately USD 877.31 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2024-2032 ...

Roche (RHHBY) announced positive topline one-year results from the open-label, single-arm phase IV ELEVATUM study evaluating Vabysmo ...

Regeneron Pharmaceuticals Inc. (REGN) announced positive three-year (156-week) data for EYLEA HD (aflibercept) Injection 8 mg from an ...

President Bola Tinubu has again been sent a packing warning as NNPP revealed dangerous permutations ahead of the 2027 ...

Data about higher doses that are injected less often come as the original 2-milligram dose of Eylea is facing an increasing ...

Christina Y Weng, MD, MBA sat down to discuss the Retina Ophthalmic Technology Assessment Symposium and her journal on ...

Dr. Arepalli discussed a course focused on ocular conditions related to pregnancy and postpartum care, presented at the ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from ...